HyStem. Hydrogels CELLULAR MATRICES FOR TRANSLATIONAL RESEARCH. esibio.com



Similar documents
3D Cell Culture mimsys G

Empower 3D cell culture with simplicity and versatility. VitroGel TM 3D. a ready-to-use hydrogel system for 3D cell culture and beyond

STEM CELL FELLOWSHIP

AAGPs TM Anti-Aging Glyco Peptides. Enhancing Cell, Tissue and Organ Integrity Molecular and biological attributes of lead AAGP molecule

Biotechnology. Srivatsan Kidambi, Ph.D.

BD PuraMatrix Peptide Hydrogel

CORNING Life Sciences

Softwell. Petrisoft. Collagen. Ultrasoft. 25 kpa. 8 kpa. Easy Coat. 1 kpa. Softview. Hydrogel-coated wells for cell culture. Non-activated 0.

CorMatrix ECM Technology

Human Embryonic and Induced Pluripotent Stem Cells: Biotechnology Entering a New Era of Complexity

STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE

Basic Science in Medicine

How To Expand Hematopoietic Stem Cells

6 Characterization of Casein and Bovine Serum Albumin

LifeNet Health Presented by James Clagett, PhD., Chief Science Officer LifeNet Health - The Best Keep Secret in Regenerative Medicine

Stem Cell Quick Guide: Stem Cell Basics

Controlled release of proteins from self-assembling hydrogels based on oppositely charged dextran microspheres

Protein immunoblotting

5 Frequently Asked Questions About Adult Stem Cell Research

San Diego Stem Cell Treatment Center Frequently Asked Questions

your complete stem cell bank

FGF-1 as Cosmetic Supplement

Additive Verfahren mit biologischen Materialien

CORD BLOOD BANKING FAQ

Human Umbilical Cord Blood CD34 + Progenitor Cell Care Manual

THE RESORBABLE MATRIX. Relax. Remaix. The membrane of choice for reliable bone and tissue regeneration

Stem Cell-based Therapies and FDA Regulations

P Havea & P Watkinson

S YN T H E T I C C A N C E L LO U S B O N E

An Overview of Cells and Cell Research

protocol handbook 3D cell culture mimsys G hydrogel

博 士 論 文 ( 要 約 ) A study on enzymatic synthesis of. stable cyclized peptides which. inhibit protein-protein interactions


A STRONG DECISION FOR A HEALTHY FUTURE

Radius 24-Well Cell Migration Assay (Laminin Coated)

Support structure for genetic material

The ethics of stem cell research and treatment

Roche Position on Human Stem Cells

Osteoblast Differentiation and Mineralization

Investor Presentation NASDAQ:BLFS

Optimal Conditions for F(ab ) 2 Antibody Fragment Production from Mouse IgG2a

PART I. SECTION 1. The legislature finds that an estimated. 128,000,000 Americans suffer from the crippling economic and

Stem Cell Therapy. Treat your pain, improve your lifestyle and look after your wellbeing. What are stem cells?

Creating a cgmp Facility for Early Clinical Trials of Molecular Imaging and Therapeutic Agents

Stem cells possess 2 main characteristics: Sources of pluripotent stem cells: -Long-term self renewal. -The inner cell mass of the blastocyst.

guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research

RITMIR024 - STEM CELL RESEARCH IN CARDIOLOGY

The Use of a Hydrogel Matrix as a Cellular Delivery Vehicle in Future Cell-Based Therapies: Biological and Non-Biological Considerations

3D Hydrogel Systems. Supporting the Growth of Neural Stem Cells BACHELOR PAPER II

Mesenchymal Stem Cells

BIOMEDICAL ENGINEERING NEURO-ONCOLOGY

STEM CELL FACTS. The ISSCR is an independent, nonproft organization providing a global forum for stem cell research and regenerative medicine.

DNA Fingerprinting. Unless they are identical twins, individuals have unique DNA

Biofibrillar/nanofibrillar cellulose hydrogel as 2D/3D cell culture material

THREE-DIMENSIONAL EXTRACELLULAR MATRIX HYDROGEL ENVIRONMENTS FOR EMBRYONIC STEM CELL GROWTH

FACULTY OF MEDICAL SCIENCE

Alexander Smolyaninov,

Unit 1 Higher Human Biology Summary Notes

SORRENTO THERAPEUTICS, INC. (Exact name of registrant as specified in its charter)

International Stem Cell Registry

The Types of stem cells: Totipotent Pluripotent Multipotent

Stem Cell Research: Adult or Somatic Stem Cells

Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC

Top Ten Things to Know About Stem Cell Treatments

DEVELOPING AND TESTING RETRIEVABLE DEVICES AND SCAFFOLDS FOR BETA CELL REPLACEMENT THERAPIES

Do you have anything to add? If so, I d love to hear from you! Jessica Robinson Conference Manager Life

Structure of proteins

Call 2014: High throughput screening of therapeutic molecules and rare diseases

Equine Stem Cells. Sources, Processing, Expansion, Storage and Shipping

Umbilical Cord Blood Stem Cells Current Status & Future Potential

HUMAN STEM CELLS DERIVED FROM CORD BLOOD REDUCES THE SIZE OF PANCREATIC TUMOR IN SCID MICE.

AFM. Atomic Force Microscopy. (Atomic) Force Microscopy. Scanning Probe Microscopy (SPM) Rasterkraftmikroskopie. A cell biologist s hands-on view

Please visit this site for the current GESCR procedures info:

JBS FUNDAMENT Thermofluor Screen

Modelling cell motion: From microscopic to macroscopic scale. Luigi Preziosi calvino.polito.it/~preziosi

Stem Cells: Scientific Progress and Future Research Directions

A Novel Bioconjugation Technology

XCM Biologic Tissue Matrix. Regenerative matrix for reinforcement and repair of soft tissue.

CIGNA HEALTHCARE COVERAGE POSITION

Methods of Grading S/N Style of grading Percentage Score 1 Attendance, class work and assignment 10 2 Test 20 3 Examination 70 Total 100

RhD typing. Practice for IV year medical students. Zita Csernus MD. National Blood Transfusion Service Blood Transfusion Centre Pécs

CHAPTER 1 INTRODUCTION

Bottlenecks in Clinical Source Material Acquisition. Aby J. Mathew, PhD May 5, 2009 ISCT Annual Meeting San Diego, CA

BioBusiness Biopharmaceutical Ingredients Recombinant albumins & albumin fusion Dermot Pearson, Strategic Product Director, NZ Biopharma

Helices From Readily in Biological Structures

CytoSelect 48-Well Cell Adhesion Assay (ECM Array, Colorimetric Format)

AUTOHEPARIN (ERC-2008-AdG) Automated Synthesis of Heparin and Chondroitin Libraries for the Preparation of Diverse Carbohydrate Arrays

Running head: STEM CELL RESEARCH 1

Patient Handbook on Stem Cell Therapies

UC Davis Institute for Regenerative Cures A facility supported by the California Institute for Regenerative Medicine

Stem Cell Collection Preservation Research Processing East Seven Mile Detroit, MI fax

Technology Breakthrough in Spinal Implants (Technical Insights)

How To Treat Leukaemia With Cord Blood Stem Cell

TITLE: Treatment of Prostate Cancer with a DBP-MAF-Vitamin D Complex to Target Angiogenesis and Tumorigenesis

Biomaterials: Production, Processing and Application

Chapter 12 - Proteins

Fabrication of alginate hydrogel scaffolds and cell viability in calcium-crosslinked alginate hydrogel

Stem cells will change medicine as we know it. Are you ready? STEM CELL BANKING

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

Transcription:

HyStem Hydrogels CELLULAR MATRICES FOR TRANSLATIONAL RESEARCH

HyStem Hydrogel Extracellular Matrices Chemically-defined For use in 2D and 3D formats in vitro and in vivo applications Customizable for many cell types Translatable to clinical applications Attaining optimal cell culture conditions is one of the greatest challenges in stem cell research. In addition to nutrient requirements, the cell s substrate has a fundamental influence on whether cells thrive, how they differentiate, and most importantly, whether they reflect cells in a native environment.

The HyStem technology HyStem hydrogels are rich in hyaluronic acid (HA) an evolutionarily conserved glycosaminoglycan with excellent water retention capabilities that is commonly found in many tissue types and species as a component of the extracellular matrix (ECM). The HyStem technology is based on the reaction between thiol-modified biopolymers and a thiol-reactive crosslinker to produce a hydrogel that gels in situ and can be used as both a cell culture scaffold and a cell delivery vehicle. In two simple steps, the material is ready for use just reconstitute components in deionized water and mix. The HyStem mixture gels at room temperature within 30 minutes with no temperature or ph adjustments required. Its two base components are synthetic molecules, thiol-modified hyaluronan (Glycosil ) and a thiol-reactive crosslinker, polyethylene glycol diacrylate, PEGDA (Extralink ). Mixing HyStem macro-molecules in the presence of the PEGDA crosslinker produces a biocompatible, resorbable hydrogel whose stiffness, viscosity, and gelation time can be precisely controlled. Why use HyStem hydrogels for cell culture? In addition to being fully-defined and consisting of components that mimic a native ECM, a further advantage of HyStem hydrogels over other matrices, is that they are easily customizable. Generally, stem cells depend on specific ECM components to grow and differentiate. To affect specific cell performance, components such as growth factors or ECM proteins can easily be incorporated covalently or non-covalently into HyStem hydrogels. Research has shown that in addition to soluble induction factors, the rigidity of a substrate on which cells are grown has a significant influence on the lineage specificity of the cell. When cells attach to a substrate (as with the ECM in vivo), they sense the rigidity and respond by remodeling their cytoskeleton according to the substrate s stiffness. The stiffness of HyStem hydrogels can be easily varied to manipulate the development of cells and tissues so they physiologically mimic cells grown in vivo. As the promise of tissue engineering and regenerative medicine becomes a reality, prospective cell based therapies will require a biocompatible, transient delivery matrix. HyStem hydrogels are available in formats made in compliance with cgmp requirements. Proteins, factors, and cells can be mixed with HyStem hydrogels and injected through a small gauge needle. Gelation occurs in situ. The resulting scaffold in vivo prevents undesired cell migration and increases cell viability. Over time, the hydrogel is replaced with ECM produced by living cells. HyStem hydrogels provide a flexible format for translational research. They can be used to culture cells in a 2D environment on cell culture plates, to encapsulate cells in a 3D ECM in vitro or to inject cells in vivo. one

HyStem HyStem-C HyStem-HP HIGHLIGHTS Blank-slate substrate - completely customizable Good starter kit with incorporated collagen binding sites Allows simultaneous growth factor, drug, and cell delivery in vivo Less growth factor required Fast (30 min), Easy-to-use, Safe (no by-products) Substrate mimics native tissue 3D use in vitro and injectable for in vivo applications Components are translatable for clinical use FEATURES Xeno-free Collagen provides general attachment protein for wide range of cells Formulation and rigidity can be customized to vary stiffness, component concentration, and gelation time ECM proteins can be introduced covalently through thiol bonds Chemically-defined Growth factors added to gel mixture ionically bind with heparin for a slow, more-controllable release COMPONENTS Thiol-modified hyaluronan (Gycosil ) Thiol-reactive PEGDA crosslinker (Extralink ) Degassed, deionized water (DG Water) Thiol-modified hyaluronan (Gycosil ) Thiol-reactive PEGDA crosslinker (Extralink ) Thiol-modified collagen (Gelin-S ) Degassed, deionized water (DG Water) Thiol-modified hyaluronan and heparin (Heprasil ) Thiol-reactive PEGDA crosslinker (Extralink ) Thiol-modified collagen (Gelin-S ) Degassed, deionized water (DG Water) HyStem Hydrogel Kit The blank-slate matrix Animal-free HyStem is a chemically-defined, synthetic matrix. The key benefit of HyStem is that it allows complete control over the design of matrix characteristics as it consists only of synthetic hyaluronan and the synthetic PEGDA crosslinker. ECM proteins can be non-covalently added to HyStem prior to crosslinking or cell attachment peptides can be covalently linked into the matrix during gelation. Figure: Cardiomyocytes grown on the surface of HyStem with fibronectin HyStem-C Hydrogel Kit The starter matrix HyStem-C provides an excellent starting point for optimizing the matrix for cell culture. HyStem-C is chemically-defined and based on three biocompatible components: thiol-modified hyaluronan (Glycosil), thiol-reactive crosslinker, PEGDA (Extralink), and thiol-modified denatured collagen (Gelin-S). Gelin-S provides basic cell-attachment sites for a wide variety of primary cells and cell lines and is therefore recommended as an ideal substrate for adherent cell types and cell culture optimization. In some cultures, HyStem-C hydrogels can be further enhanced by the addition of ECM proteins to match native signals. HyStem-HP Hydrogel Kit The growth factor delivery matrix HyStem-HP is chemically-defined and is ideal for cell applications whereby the slow, continuous release of growth factors is crucial to re-creating a desired microenvironment. The HyStem-HP hydrogel kit contains a combination of thiol-modified hyaluronan and a thiol-modified heparin (Heprasil ), thiol-modified denatured collagen (Gelin-S), and thiol-reactive crosslinker, PEGDA (Extralink). The immobilized heparin in the HyStem-HP hydrogel mimics the heparin sulfate proteoglycans normally present in the extracellular matrix. Heparin forms an ionic bond with proteins which protects them from proteolysis and facilitates their slow release into the cell culture medium. This significantly reduces the amount of growth factor required to trigger cell growth or differentiation compared to when growth factors are added directly to the medium. two

The following cells have been cultured using HyStem: Human embryonic stem cells (H9s) Umbilical cord blood CD34+ stem cells Hepatic stem cells Hepatic progenitor cells Adipose-derived stem cells Cardiomyocytes Mesenchymal stem cells Bone marrow-derived mesenchymal stem cells Neural progenitors Pancreatic islet cells A549 lung cancer cells HUES-7 hescs Considerations to take into account when choosing an appropriate substrate for translational research include: The ability to customize the substrate to mimic native conditions Flexibility for 2D and 3D environments in vitro and sustainability in vivo Full knowledge of substrate composition no contaminating factors Likelihood of components to be translatable to clinical applications Fibroblasts Whether your requirements mandate an animal-free system or your research requires the ability to incorporate growth factors and peptides into your stem cell culture system, there is a HyStem hydrogel kit to meet the needs of your translational research. three

Your partner in translating scientific discoveries ESI BIO s mission is to be our customer s trusted partner in translating scientific discoveries to the clinic. We do this by providing breakthrough stem cell technologies as research grade and therapeutic grade products, lighting the path from research to the clinic in order to help our customers with their goal of treating disease. HyStem Hydrogels Description HyStem Hydrogel Kit HyStem -C Hydrogel Kit HyStem -HP Hydrogel Kit Size 1 1 1 Cat. No. GS310 GS311 GS1004 GS312 GS313 GS1005 GS314 GS315 GS1006 HyStem Hydrogels with PEGSSDA Description HyStem Hydrogel Kit w/ PEGSSDA HyStem -C Hydrogel Kit w/ PEGSSDA HyStem -HP Hydrogel Kit w/ PEGSSDA Size Cat. No. GS310P GS311P GS312P GS313P GS314P GS315P four

Lighting the path from research to therapy. Toll-free 877. 636.4978 t 510.521.3390 f 510.648.3255 orders@ ESI BIO 2014. Unless otherwise noted, ESI BIO, ESI BIO logo and all other trademarks are the property of BioTime, Inc. V1 JUNE 2014

1301 Harbor Bay Parkway I Suite 100 I Alameda, California 94502 t 877.636.4978 f 510.648.3255 I